v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating expenses      
Research and development expenses $ 129,844 $ 105,581 $ 51,858
Selling, general and administrative expenses 26,529 23,104 32,856
New warrants expenses 0 1,863 104,776
Total operating expenses 156,374 130,549 189,490
Operating loss (156,374) (130,549) (189,490)
Gain/(loss) from derivative liabilities 6,983 (10,403) 9,548
Financial investment income 12,299 11,672 5,073
Related party loan interest income 2,875 4,385 1,650
Interest expense (3,661) (252) 0
Other (loss)/gain, net 218 (945) 122
Loss before income taxes (137,661) (126,091) (173,097)
Income tax expense 507 1,568 933
Net loss $ (138,168) $ (127,658) $ (174,030)
Weighted-average number of shares outstanding – basic (in shares) 288,524 275,763 254,131
Weighted-average number of shares outstanding – diluted (in shares) 288,524 275,763 254,131
Net loss per share – basic (in dollars per share) $ (0.48) $ (0.46) $ (0.68)
Net loss per share – diluted (in dollars per share) $ (0.48) $ (0.46) $ (0.68)

Source